发明名称 USE OF ROTIGOTINE FOR THE TREATMENT OR PREVENTION OF DOPAMINERGIC NEURONE LOSS
摘要 The invention relates to the use of rotigotine or salts thereof and prodrugs for the production of a medicament for the treatment or prevention of dopaminergic cell destruction in diseases which are connected to increased dopaminergic cell destruction. The invention also relates to the use of rotigotine as a medicament for the preventive treatment of Parkinson's disea se.
申请公布号 CA2547645(A1) 申请公布日期 2005.07.14
申请号 CA20042547645 申请日期 2004.12.23
申请人 SCHWARZ PHARMA AG 发明人 SCHELLER, DIETER;DRESSEN, FRANK
分类号 A61K31/381;A61P25/16 主分类号 A61K31/381
代理机构 代理人
主权项
地址